CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Elevated night-time BP increases CV event risk in hypertensive diabetics


18 August 2010

MedWire News: Patients with diabetes and hypertension have an increased risk for adverse cardiovascular events (CVE) and/or albuminuria if they have higher nocturnal than daytime blood pressure (BP), a Brazilian study suggests.

Joao Felício (Universidade Federal do Pará, Belém) and colleagues explain that autonomic neuropathy – which can arise from a state of hyperglycemia – may account for the nocturnal BP elevation observed in some patients with diabetes.

The researchers performed baseline and 2-year, 24-hour ambulatory BP measurement on 70 hypertensive patients with diabetes.

All patients had normal urinary albumin excretion (UAE), urinary protein excretion (UPE), and excretion glomerular filtration rate (eGFR) at baseline.

Over a 2-year follow-up period, 11 patients developed diabetic nephropathy (DN) and four suffered a CVE, defined as myocardial infarction, stroke, or angina.

Writing in the journal Cardiovascular Diabetology, the team reports that all patients had similar daytime systolic and diastolic BP.

However, the findings for night-time BP differed, with higher systolic and diastolic BP among the patients with DN or CVE compared with those without these conditions, at 138 versus 129 mmHg, and 83 versus 75 mmHg, respectively.

Basal nocturnal systolic BP was positively associated with DN, CVE, and end-of-study UAE, however, a fall in basal systolic and diastolic nocturnal BP was negatively associated with end-of-study UAE.

Patients who developed DN had smaller nocturnal BP reductions compared with those without DN, with a mean systolic and diastolic BP reduction of 3 versus 12 mmHg, and 4 versus 15 mmHg, respectively.

Felício et al conclude that the lack of normal nocturnal BP fall associated with increased risk for CVE and DN may be due to “other conditions, such as obstructive sleep apnea and renal failure with fluid retention.”

They therefore call for other studies to investigate the mechanism by which nocturnal BP changes arise in patients with diabetes.

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Cardiovasc Diabetol 2010; 9: 36



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions